Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in Japan (CHOICE)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Kyoto, Japan, 606-8507
- Division of Cardiology, Kyoto University Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients scheduled for percutaneous coronary intervention due to ischemic heart disease
- Patients taking aspirin 81-100mg at least 1 week.
Exclusion Criteria:
- Patients with ST elevation myocardial infarction
- Patients have contraindication of aspirin or clopidogrel
- Patients taking warfarin
- Patients received thrombolytic therapy within 2 weeks
- Patients taking anti-platelet agents except aspirin within 1 month
- Patients taking corticosteroid.
- Patients taking proton pump inhibitor
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: High loading and high maintenance
Clopidogrel loading 600mg and maintenance 150mg for 7days
|
Clopidogrel loading 600mg and maintenance 150mg for 7days
Clopidogrel loading 600mg and maintenance 75mg for 7days
Clopidogrel loading 300mg and maintenance 150mg for 7days
Clopidogrel loading 300mg and maintenance 75mg for 7days
|
|
Active Comparator: High loading and low maintenance
Clopidogrel loading 600mg and maintenance 75mg for 7days
|
Clopidogrel loading 600mg and maintenance 150mg for 7days
Clopidogrel loading 600mg and maintenance 75mg for 7days
Clopidogrel loading 300mg and maintenance 150mg for 7days
Clopidogrel loading 300mg and maintenance 75mg for 7days
|
|
Active Comparator: Low loading and high maintenance
Clopidogrel loading 300mg and maintenance 150mg for 7days
|
Clopidogrel loading 600mg and maintenance 150mg for 7days
Clopidogrel loading 600mg and maintenance 75mg for 7days
Clopidogrel loading 300mg and maintenance 150mg for 7days
Clopidogrel loading 300mg and maintenance 75mg for 7days
|
|
Active Comparator: Low loading and low maintenance
Clopidogrel loading 300mg and maintenance 75mg for 7days
|
Clopidogrel loading 600mg and maintenance 150mg for 7days
Clopidogrel loading 600mg and maintenance 75mg for 7days
Clopidogrel loading 300mg and maintenance 150mg for 7days
Clopidogrel loading 300mg and maintenance 75mg for 7days
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Inhibition of platelet aggregation 24 hours after loading
Time Frame: 24 hours
|
24 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
myocardial infarction
Time Frame: 1 year
|
1 year
|
|
all cause death
Time Frame: 1 year
|
1 year
|
|
Inhibition of platelet aggregation 7 days after loading
Time Frame: 7 days
|
7 days
|
|
Inhibition of platelet aggregation 28 days after loading
Time Frame: 28 days
|
28 days
|
|
cardiac death
Time Frame: 1 year
|
1 year
|
|
stent thrombosis (Academic Research Consortium definition)
Time Frame: 1 year
|
1 year
|
|
acute hemorrhagic or ischemic stroke excluding transient ischemic attack
Time Frame: 1 year
|
1 year
|
|
bleeding complications (Global Use of Strategies to Open Occluded Coronary Arteries [GUSTO] and Thrombolysis In Myocardial Infarction [TIMI] definition)
Time Frame: 1 year
|
1 year
|
|
composite of cardiac death, myocardial infarction and stroke
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Takeshi Kimura, MD, Professor of Medicine, Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Heart Diseases
- Cardiovascular Diseases
- Vascular Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Coronary Artery Disease
- Myocardial Ischemia
- Coronary Disease
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Platelet Aggregation Inhibitors
- Purinergic P2Y Receptor Antagonists
- Purinergic P2 Receptor Antagonists
- Purinergic Antagonists
- Purinergic Agents
- Clopidogrel
Other Study ID Numbers
Other Study ID Numbers
- C369
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.